Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 71

    1.

    Expensive drugs for rare disorders: to treat or not to treat? The case of enzyme replacement therapy for mucopolysaccharidosis VI.

    Schlander M, Beck M.

    Curr Med Res Opin. 2009 May;25(5):1285-93. Review.PMID: 19366306 [PubMed - indexed for MEDLINE]Related articles

    2.

    Treatment options for HUS secondary to Escherichia coli O157:H7.

    Bitzan M.

    Kidney Int Suppl. 2009 Feb;(112):S62-6. Review.PMID: 19180140 [PubMed - indexed for MEDLINE]Related articles

    3.

    A unifying strategy for clinical trials in rare urological malignancy.

    Nicholson S.

    Nat Clin Pract Urol. 2008 Dec;5(12):652-3. Epub 2008 Nov 18. Review. No abstract available. PMID: 19015645 [PubMed - indexed for MEDLINE]Related articles

    4.

    International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions.

    Norman R, Haas M, Wilcken B.

    Health Policy. 2009 Mar;89(3):252-60. Epub 2008 Sep 26. Review.PMID: 18823674 [PubMed - indexed for MEDLINE]Related articles

    5.

    Rare childhood diseases: how should we respond?

    Zurynski Y, Frith K, Leonard H, Elliott E.

    Arch Dis Child. 2008 Dec;93(12):1071-4. Epub 2008 Aug 6. Review.PMID: 18684747 [PubMed - indexed for MEDLINE]Related articles

    6.

    Optimal therapy for rare disorders and genetic diseases: ethical and political challenges.

    MacLeod S.

    Proc West Pharmacol Soc. 2007;50:21-3. Review.PMID: 18605224 [PubMed - indexed for MEDLINE]Related articles

    7.

    Gene therapy of inherited diseases.

    Fischer A, Cavazzana-Calvo M.

    Lancet. 2008 Jun 14;371(9629):2044-7. Review. No abstract available. PMID: 18555917 [PubMed - indexed for MEDLINE]Related articles

    8.

    Why rare diseases are an important medical and social issue.

    Schieppati A, Henter JI, Daina E, Aperia A.

    Lancet. 2008 Jun 14;371(9629):2039-41. Review. No abstract available. PMID: 18555915 [PubMed - indexed for MEDLINE]Related articles

    9.

    Unusual tumors of the thyroid gland.

    Baloch ZW, LiVolsi VA.

    Endocrinol Metab Clin North Am. 2008 Jun;37(2):297-310, vii. Review.PMID: 18502328 [PubMed - indexed for MEDLINE]Related articles

    10.

    Developing a national collaborative study system for rare genetic diseases.

    Watson MS, Epstein C, Howell RR, Jones MC, Korf BR, McCabe ER, Simpson JL.

    Genet Med. 2008 May;10(5):325-9.PMID: 18496030 [PubMed - indexed for MEDLINE]Related articles

    11.

    The Greig cephalopolysyndactyly syndrome.

    Biesecker LG.

    Orphanet J Rare Dis. 2008 Apr 24;3:10. Review.PMID: 18435847 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases.

    van der Lee JH, Wesseling J, Tanck MW, Offringa M.

    J Clin Epidemiol. 2008 Apr;61(4):324-30. Epub 2008 Feb 21. Review.PMID: 18313556 [PubMed - indexed for MEDLINE]Related articles

    13.

    Networking for rare diseases: a necessity for Europe.

    Aymé S, Schmidtke J.

    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Dec;50(12):1477-83. Review.PMID: 18026888 [PubMed - indexed for MEDLINE]Related articles

    14.

    Impacts of national surveillance for uncommon conditions in childhood.

    Zurynski YA, Peadon E, Bower C, Elliott EJ.

    J Paediatr Child Health. 2007 Nov;43(11):724-31. Review.PMID: 17924937 [PubMed - indexed for MEDLINE]Related articles

    15.

    A patient and family perspective on gene therapy for rare diseases.

    Kent A, Oosterwijk C.

    J Gene Med. 2007 Oct;9(10):922-3. Review.PMID: 17880044 [PubMed - indexed for MEDLINE]Related articles

    16.

    Autoinflammatory syndromes with a dermatological perspective.

    Kanazawa N, Furukawa F.

    J Dermatol. 2007 Sep;34(9):601-18. Review.PMID: 17727363 [PubMed - indexed for MEDLINE]Related articles

    17.

    Access to information supporting availability of medicines for patients suffering from rare diseases looking for possible treatments: the EuOrphan Service.

    Stakisaitis D, Spokiene I, Juskevicius J, Valuckas KP, Baiardi P.

    Medicina (Kaunas). 2007;43(6):441-6. Review.PMID: 17637514 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Inhibitor development in haemophilia B: an orphan disease in need of attention.

    DiMichele D.

    Br J Haematol. 2007 Aug;138(3):305-15. Review.PMID: 17614818 [PubMed - indexed for MEDLINE]Related articles

    19.

    Rare and real illnesses that affect our students.

    Ilardi D.

    School Nurse News. 2007 Mar;24(2):16-21. Review. No abstract available. PMID: 17393820 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design.

    Behera M, Kumar A, Soares HP, Sokol L, Djulbegovic B.

    Cancer Control. 2007 Apr;14(2):160-6. Review.PMID: 17387301 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...